Skip to main content

Biomedical Applications of Radioactive ion Beams

Project description

Improving the applicability of cancer radiotherapy

Charged particle therapy (CPT) using accelerated protons or heavy ions offers certain advantages compared to standard cancer radiotherapy using X-rays. However, issues regarding range uncertainty and poor image guidance limit the widespread applicability of CPT in cancer therapy. The EU-funded BARB project aims to address this problem by employing high-intensity radioactive ion beams that will enable the treatment of small lesions with unprecedented precision. In addition, to facilitate simultaneous treatment and visualisation, scientists will develop an innovative hybrid detector that combines positron emission tomography (PET) and gamma ray imaging. Considering that nearly 50 % of cancer cases undertake radiotherapy treatment, this optimised CPT approach will improve treatment outcome in a significant number of patients.

Host institution

GSI HELMHOLTZZENTRUM FUR SCHWERIONENFORSCHUNG GMBH
Net EU contribution
€ 2 000 000,00
Address
Planckstrasse 1
64291 Darmstadt
Germany

See on map

Region
Darmstadt Darmstadt, Kreisfreie Stadt
Activity type
Other
Other funding
€ 0,00

Beneficiaries (2)

GSI HELMHOLTZZENTRUM FUR SCHWERIONENFORSCHUNG GMBH
Germany
Net EU contribution
€ 2 000 000,00
Address
Planckstrasse 1
64291 Darmstadt

See on map

Region
Darmstadt Darmstadt, Kreisfreie Stadt
Activity type
Other
Other funding
€ 0,00
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Germany
Net EU contribution
€ 500 000,00
Address
Geschwister Scholl Platz 1
80539 Muenchen

See on map

Region
Bayern Oberbayern München, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00